Astria Therapeutics Inc (ATXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 706 | 0 | 0 | 0 | 0 |
| Gross Profit | 706 | N/A | N/A | N/A | N/A |
| Operating Expenses | 34,810 | 35,820 | 36,995 | 29,591 | 29,014 |
| Operating Income | -34,104 | -35,820 | -36,995 | -29,591 | -29,014 |
| Other Income | 2,461 | 2,768 | 3,286 | 3,965 | 4,480 |
| Pre-tax Income | -31,643 | -33,052 | -33,709 | -25,626 | -24,534 |
| Net Income Continuous | -31,643 | -33,052 | -33,709 | -25,626 | -24,534 |
| Net Income | $-31,643 | $-33,052 | $-33,709 | $-25,626 | $-24,534 |
| EPS Basic Total Ops | -0.55 | -0.57 | -0.58 | -0.45 | -0.42 |
| EPS Basic Continuous Ops | -0.55 | -0.57 | -0.58 | -0.45 | -0.42 |
| EPS Diluted Total Ops | -0.55 | -0.57 | -0.58 | -0.45 | -0.42 |
| EPS Diluted Continuous Ops | -0.55 | -0.57 | -0.58 | -0.45 | -0.42 |
| EPS Diluted Before Non-Recurring Items | -0.55 | -0.57 | -0.58 | -0.44 | -0.42 |
| EBITDA(a) | $-34,104 | $-35,820 | $-36,995 | $-29,591 | $-29,014 |